News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MediQuest Thera Raises $23M To Break Ground With Raynaud's Drug



5/29/2009 10:31:23 AM

VentureWire -- MediQuest Therapeutics Inc. has secured $23 million toward a Series B to take a second shot at introducing the first drug for the autoimmune condition Raynaud's disease.

Read at Dow Jones


comments powered by Disqus
Dow Jones
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES